<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a randomized pilot study we compared the efficacy of temporary anticoagulation with intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> <z:chebi fb="199" ids="26708">sodium</z:chebi> to the efficacy of aspirin in preventing <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> in hospitalized patients with recent (less than 7 days) <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> (<z:hpo ids='HP_0002326'>TIAs</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>Fifty-five patients (33 men, 22 women) aged 36-81 (mean 62.7) years met entry criteria and agreed to participate </plain></SENT>
<SENT sid="2" pm="."><plain>Symptoms prompting hospitalization were referable to the carotid distribution in 43 patients (34 hemispheric, nine <z:chebi fb="46" ids="15035">retinal</z:chebi>); 12 patients had vertebrobasilar distribution <z:hpo ids='HP_0002326'>TIAs</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty-seven patients received <z:chebi fb="5" ids="28304">heparin</z:chebi> and 28 received aspirin </plain></SENT>
<SENT sid="4" pm="."><plain>Patients were treated until surgery or until long-term medical therapy was instituted, 3-9 (mean 5.5) days in the <z:chebi fb="5" ids="28304">heparin</z:chebi> group and 3-15 (mean 5.8) days in the aspirin group </plain></SENT>
<SENT sid="5" pm="."><plain>Recurrent <z:hpo ids='HP_0002326'>TIAs</z:hpo> occurred in eight patients given <z:chebi fb="5" ids="28304">heparin</z:chebi> and in seven treated with aspirin </plain></SENT>
<SENT sid="6" pm="."><plain>Infarction occurred in one patient in the <z:chebi fb="5" ids="28304">heparin</z:chebi> group and in four patients in the aspirin group (three brain, one <z:chebi fb="46" ids="15035">retinal</z:chebi> infarction) </plain></SENT>
<SENT sid="7" pm="."><plain>Initial symptoms in these five patients were referable to the carotid distribution in two and to the vertebrobasilar distribution in three </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients but the one with a <z:chebi fb="46" ids="15035">retinal</z:chebi> infarction had recurrent <z:hpo ids='HP_0002326'>TIAs</z:hpo> prior to <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Our pilot study suggests that hospitalized patients with recent <z:hpo ids='HP_0002326'>TIAs</z:hpo> are at high risk for recurrent <z:hpo ids='HP_0002326'>TIAs</z:hpo> (15 of 55, 27%) and <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (five of 55, 9%) and that patients with recent vertebrobasilar distribution <z:hpo ids='HP_0002326'>TIAs</z:hpo> have a marginally significantly higher risk (odds ratio 6.83, 95% confidence interval 0.65-88.66) of infarction than patients with recent carotid distribution <z:hpo ids='HP_0002326'>TIAs</z:hpo> </plain></SENT>
</text></document>